An Orphan Disease Gets Adopted

Courtesy of Ed Rowton, Walter Reed Army Institute of Research An anopheline mosquito taking a blood meal. Researchers and physicians, open your guides to rare diseases, for that may be the only place you'll encounter Jumping Frenchmen of Maine. There you also will find Kabuki Make-up Syndrome, Split-Hand Deformity, Stiff Person Syndrome, Tangier Disease, and Twin-Twin Transfusion Syndrome. These are among thousands of "orphan diseases," originally so called because they weren't "adopted" by spon

Written bySteve Bunk
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Courtesy of Ed Rowton, Walter Reed Army Institute of Research

An anopheline mosquito taking a blood meal.
Researchers and physicians, open your guides to rare diseases, for that may be the only place you'll encounter Jumping Frenchmen of Maine. There you also will find Kabuki Make-up Syndrome, Split-Hand Deformity, Stiff Person Syndrome, Tangier Disease, and Twin-Twin Transfusion Syndrome. These are among thousands of "orphan diseases," originally so called because they weren't "adopted" by sponsors of new drugs to treat or prevent them. Yet, orphan diseases also include such terribly familiar names as tuberculosis, cholera, typhoid, and malaria. That's because those maladies are more prevalent in the poor marketplace of developing countries than in the developed world, a fact providing little financial incentive for the private sector to make new medications.

In the case of malaria, however, government and foundation initiatives are under way, with private sector involvement, including a commitment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies